Common BMT abbreviations & diseases Flashcards

(75 cards)

1
Q

AML*

A

acute myelogenous leukemia

=================================
- uncontrolled/cancerous growth of abnormal and immature blood cells (aka “leukemic blasts) of the myeloid line
- rapid onset

Pathology:
- acquired genetic damage of a developing stem cell in the bone marrow
- blasts “crowds out” normal cells
* causing function failure of the normal cells
* blocking the production of normal cells

S & S:
- leukemic cell growth in the marrow +/- the peripheral blood
- impaired production of normal cells
- anemia, thrombocytopenia, infections

Special considerations:
- HYPERLEUKOCYTOSIS
high WBC count (> 100/ul) which manifests by “sludging” of cells in the smaller blood vessels resulting venous engorgement in fundus of eye, headaches, altered mental orientation, SOB, pulmonary infiltrates, chest pain with myocardial ischemia, renal insufficiency etc.
- may consider leuko-reduce via apheresis prior to giving chemotherapy

Tx: Allopurinol (for build up of uric acid from cell breakdown)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

APL (AML-M3)*

A

acute promyelocytic leukemia

=====================================
a type of AML associated with a translocation of genes between chromosome 15 and 17

Tx: ATRA (All- Trans Retinoic Acid) and ATO (arsenic trioxide), not required transplantation in many cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Etiology of AML

A
  • high dose irradiation exposure
  • chronic benzene exposure
  • alkylating agents in chemotherapy
  • therapeutic radiation (dose and duration of exposure dependent)
  • tobacco smoke
  • CML
  • Down’s Syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ALL*

A

acute lymphocytic leukemia

================================
- cancerous growth of blood cells of lymphocytic line
- lymphoblasts seen in the marrow
- 88% from B lymphocyte development
- 12% from T lymphocyte development

Category:
Acute T lymphoblastic leukemia
Acute B lymphoblastic leukemia (pre-B cell lymphoblastic leukemia)

**Philadelphia (Ph chromosome) –> abnormalities of chromosome 22 change; poor prognosis and requires transplant for any hope of a cure

S&S:
- same as AML
- enlarge lymph nodes due to accumulation of lymphoblasts
- headaches and vomiting due to accumulation of lymphoblasts in lining of brain and spinal cord

Tx: intensive 3 year post-remission regimen = numerous LPs to treat the sanctuary sites of the spinal column, BMT (option for high risk pts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CML*

A

chronic myelogenous leukemia

=================================
WBC and platelets mature and generally can function normally. Philadelphia chromosome translocation (t9;22) always present. Less severe early course of the disease

3 phrases:
1. CHRONIC - blood functions near normal; last for a couple of years
2. ACCELERATED - WBC and platelets may become abnormal, spleen may enlarge and pt feels ill; pts lose response to Tx
3. BLAST CRISIS - very abnormal counts, bleeding and infection occur, the usual S&S of AML show up [poor prognosis]

S&S:
- bone pain
- fever
- night sweats
- weight loss
- easy bruising
- +/- left-sided abdominal pain due to enlargement of spleen

Tx: Gleevec (Imatinib), BMT (option dependent on phase of disease, age and comorbidities)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CMML

A

chronic myelomonocytic leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CLL*

A

chronic lymphocytic leukemia

==================================
slow-growing cancer of the lymphocyte which
- normally resides in blood, bone marrow, lymph glands and spleen
- may be characterized by an isolated elevation in the blood lymphocyte count ONLY, or
- may be associated with enlarged lymph glands, liver +/- spleen
- minimal change in blood counts and remain stable for relatively long time (5-20 years)

Tx: BMT (related/unrelated) for pts <= 65 years post induction failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MDS*

A

myelodysplastic syndrome

===============================
- a group of disease in which the production of blood cells is SEVERELY DISRUPTED
- ~ 50% develop into AML, called “pre-leukemia”
- non-curable in most cases

Pathology:
- a significant proportion of blood cells are destroyed in the bone marrow due to their poor quality
- increased amount of blasts (abnormal immature blood cells), remained < 25%
- abnormally low RBCs, WBCs and platelets
- mature blood cells may not work properly

Tx: mainly supportive, BMT in younger pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MM*

A

multiple myeloma

============================
- a malignant cancer of plasma cells (develops from B lymphocytes and produce antibodies)
- non-curable disease of the elderly

Pathology:
- increased breakdown in the bone resulting in “holes” in the bone structure
- also results in pathological fractures and spinal cord compression
- hypercalcemia (leading to kidney damage)

Tx: Pamidronate (once monthly), Allo transplant (optional)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AA

A

aplastic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HLH

A

hemophagocytic lymphohistocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DLBCL

A

diffuse large B-cell lymphoma
[most common type of non-Hodgkin lymphoma (NHL)]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SAA*

A

severe aplastic anemia

==============================
- not a bone marrow cancer
- an acquired disease that is characterized by failure of producing all types of blood cells
- fat cells present

Pathology:
- an abnormal response by pt’s own immune system directed against the bone marrow (autoimmune effect)
- low blood cell counts therefore at risk of infection and bleeding

Tx: immunosuppression (ATG/prednisone/Cyclosporine)

If in remission, pt will be maintained on a tapering CSA
if relapse, pt will be re-introduced CSA
**BMT may be required in extreme cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PH +/-

A

Philadelphia chromosome positive/negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lymphoma*

A
  • a group of cancers in the lymphatic system
  • ONLY affect lymphoid line
  • generally found outside the marrow
  • malignant growth of lymphocyte crowding out healthy cells
  • can start in and be spread to almost any part of the body

2 main groups:
Hodgkin’s
Non-Hodgkin’s

Tx: Chemo, Radiation, sometimes BMT. Auto transplant preferred since bone marrow is healthy), dependent on age, stage, type and grade of disease, and general health

Remission - based on number of lymph nodes remaining after treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Non- Hodgkin’s Lymphoma (NHL)*

A
  • usually more widespread at diagnosis
  • less regular, less predictable

Category:
- based on characteristics of cancerous cells
- indolent/ aggressive, OR
- low, intermediate, high grade

High grade = very aggressive
1. Burkitt’s
2. Lymphoblastic lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Burkitt’s lymphoma*

A

Very aggressive NHL
a fastest growing tumor
doubling in size q24hrs
poor prognosis depending on tumor size, if marrow is involved
high risk of tumor lysis syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lymphoblastic lymphoma*

A

affects T cells line
mostly young men
poor prognosis if marrow is involved

intermediate grade –> large cell lymphoma
low grade –> Follicular lymphoma (very slow growing and very hard to cure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hodgkin’s lymphoma*

A

a specialized form of lymphoma characterized by
1. present of REED STERNBERG CELL (a large malignant cell found in the hodgkin’s lymphoma tissues)
2. higher incidence in adolescents and young adults
3. cure rates > 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ARA-C

A

Cytarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

BCNU

A

Carmustine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

VP16

A

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Flu

A

Fludarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Bu

A

Busulfan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
TBI*
total body irradiation =========================== Conditioning goal - immunosuppression and marrow ablation Therapeutic goal - eradiation of malignant cells Advantage: 1. is able to reach sanctuary sites (eg. testes, CNS, skin) 2. dose homogeneity (dose distribution is even over the entire body) 3. no cross-reaction with other agents used for preconditioning Tx 4. no concerns related to excretions 5. dose distribution can be tailored (shielding/boosting)
26
Cy or CTX
Cyclophosphamide
27
ATG
Anti-thymocyte globulin (rabbit)
28
ATRA
All-Trans Retinoic Acid
29
CSA
Cyclosporine
30
MMF
Mycophenolate
31
Induction
initial chemotherapy regimen given on diagnosis
32
salvage
chemotherapy regimen given when patient is not in remission
33
consolidation
chemotherapy regimen given once a remission is achieved
34
SCT
steam cell transplant
35
RIC / RICT
reduced intensity conditioning transplant
36
ALLO
allogeneic transplant
37
AUTO
autologus transplant
38
MUD
matched unrelated donor
39
VUD
volunteer unrelated donor
40
Sib ALLO
sibling allogeneic transplant
41
PBSCT
peripheral blood stem cell transplant
42
syngeneic
Allo transplant where identical twin donated the cells
43
DMSO
Dimethyl Sulfoxide - preservative in cryopreserved SCT
44
GVDH
graft vs. host disease
45
BOOP
bronchiolitis obliterans with organizing pneumonia
46
COP
cryptogenic organizing pneumonia
47
TLS
tumor lysis syndrome ======================= a fatal metabolic disorder when cytotoxic drugs rapidly destroy tumor cells Pathology: large amount of intracellular contents from the injured cells are excreted into the extracellular circulation which makes difficult for kidney to process and eliminate the cellular by-products causing metabolic disorders. S&S - metabolic acidosis - neuromuscular irritability (eg. muscle cramping, twitching, paresthesia) - renal impairment/failure - cardiac impairment (eg. dysrhythmia, arrest) - GI disorders (diarrhea, increased bowel sounds) - seizures Expected lab values: elevated - uric acid, K, Phos, BUN, LDH, Creatinine low - Ca, Mg Tx: - hydration - maintain fluid balance - electrolytes replacement as necessary - Allopurinol - radiotherapy may be used in lymphomas (where cancer infiltrates kidneys) Nursing management: - pt and family education - observe for S&S above - administer meds and IV fluids as ordered
48
DIC
disseminated intravascular coagulation ============================ - an accelerated clotting process and leads to consumption of circulating clotting factors and platelets resulting in dramatic risks for bleeds and organ failure - in ~85% of APL Pathology: large intracellular contents from breakdown of the promyelocytic cells spill into circulation initiating clotting cascade S&S: - bleeding - thrombosis - altered respiratory status - altered neurological status - renal impairment - hepatic impairment Expected lab values: platelet count - low fibrinogen - low INR/PT - prolonged PTT - prolonged D-dimer assay - +ve Tx: ATRA Allopurinol hyperhydration possible apheresis FFP **platelets not commonly given EXCEPT to pts with DIC associated with APL Nursing management: - observe for S&S above - draw blood work - prevent injury or falls - maintain acute I/O - pt and family education re: DIC and intervention used - administer meds and blood products as ordered
49
Differentiation Syndrome (Retinoic Acid Syndrome)
- a potentially fatal complication of induction chemotherapy - a "cytokine storm" in which the release of inflammatory cytokines from malignant promyelocytes cause all the pathophysiologic consequences - ~25% pt with induction treatment of ATRA and ATO for APL Pathology: release of inflammatory vasoactive cytokines causes capillary leak, fever, edema, rash, and hypotension; may link to maturation of promyelocytes induced by ATRA or ATO, followed by tissue infiltration by the mature cells Risk factors: - elevated WBC count at diagnosis - rapidly increasing WBC count - expression of CD13 on APL blasts - elevated BMI S&S: - dyspnea - edema - unexplained fever - hypotension - weight gain of > 5kg - musculoskeletal pain - diffused erythematous rash Tx: - IV Dexamethasone 10mg IV q12h x 6 doses --> reassess **Dexamethasone should be started ASAP - ATRA/ATO stops when the differentiation syndrome rapidly progress or moderate severe - supportive care as necessary (pt are quite sick and require more care) Nursing management: - pt and family education - observe for respiratory distress and fever during and after drug administration - maintain acute I/O - daily weight - Administer medications and IV fluids as ordered
50
PCP penumonia
Pneumocystic carinii pneumonia
51
Feb Neut
febrile neutropenia
52
VOD
veno-occulsive disease
53
VZV
Vericella Zoster Virus (shingles)
54
HSV
Herpes Simplex Virus
55
CMV
Cytomegalovirus
56
SOS
Sinusoidal Obstructive Syndrome ( new name for VOD)
57
BMBx
bone marrow biopsy
58
TPN
total parental nutrition
59
CBI
continuous bladder irrigation
60
PPO
pre printed orders
61
CR
complete remission
62
ESBL E.coli
extended spectrum beta lactamase E. coli
63
CIVI
continuous intravenous infusion
64
BC
blood cultures
65
PCA
patient controlled analgesic
66
BW
blood work
67
HL
Hickman line
68
PICC
peripheral inserted central catheter
69
PIV
peripheral IV
70
PRBC
packed red blood cells
71
Plts
platelets
72
cryo
cryoprecipitate
73
FFP
fresh frozen plasma
74
IVIG
intravenous immune globulin
75
HLA
human leukocyte antigen